Earningsreport

Q2/2024 6/30/2024 EPS -0.200 ZacksConsensus -0.290 ActVsEst 0.090 - Beat

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases